Rubicon Research Limited
RUBICON

Rubicon Research Limited

Healthcare
Share price
1,725
Market cap
₹28,558 Cr
1Y return
175%

A pharmaceutical company engaged in the development, manufacturing, and commercialization of differentiated drug formulations across multiple therapeutic areas. Incorporated in 1999, the company specializes in creating specialized formulations that address specific medical needs in the Indian healthcare market. Its integrated operations span research and development, manufacturing of quality pharmaceuticals, and distribution. The company distinguishes itself through its focus on bringing innovative, differentiated solutions to patients and healthcare providers.

Investors holding Rubicon Research Limited

Amansa Holdings
Amansa Holdings
Foreign Investor
3.12%
Fidelity
Fidelity
Foreign Investor
1.42%
Nomura
Nomura
Foreign Investor
1.35%

Latest move

NomuraDecreased
Nomura decreased its stake in Rubicon Research Limited from 1.68% to 1.35%, selling 541,055 shares for ₹81.19 crore at ₹1500.80 apiece. This reduced Nomura's total holdings to 2,239,895 shares.
19 Jul 2026Sign in to read more

Whales made 2 more moves in Rubicon Research Limited

Sign in to see who is buying and selling.

Sign in to find out